CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...
Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT ...
Rhi Magnesita India has informed the exchanges that its Board of Directors has approved the appointment of Alvaro Martin ...
New research has shown how brain cells acquire a cancerous mutation and spread across the cortex, opening a new path for ...
Streaming services offer a wide variety of yule log videos for those who lack a real fireplace. YouTube provides many free yule log options, including some from musical artists and Marvel. Major ...
Dec 3 (Reuters) - OpenAI must produce millions of anonymized chat logs from ChatGPT users in its high-stakes copyright dispute with the New York Times (NYT.N), opens new tab and other news outlets, a ...
Many logs became forces of destruction in Indonesia last week, in a sign that deforestation compounded the devastation wrought by a cyclone. Many logs became forces of destruction in Indonesia last ...
An expert discusses the expanded treatment options for refractory ITP, emphasizing accurate diagnosis, combination therapies targeting platelet production and destruction, and the evolving role of ...
Want to know why your high-value pages aren’t getting indexed? Or why Google keeps crawling useless parameters over and over and over…but not your blog? Your server logs hold the answers. Yes, they’re ...
Last week, OpenAI raised objections in court, hoping to overturn a court order requiring the AI company to retain all ChatGPT logs “indefinitely,” including deleted and temporary chats. But Sidney ...
Stephanie Watel is a writer on Game Rant. She has three years of experience writing about all things video games, from news to in-depth guides in a variety of genres. Her strongest niches start with ...
Preliminary results of fruquintinib in combination with FOLFIRI as second-line treatment for RAS-mutant metastatic colorectal cancer: A prospective, single-center phase 2 study. Efficacy and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results